{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:58:27Z","timestamp":1787803107612,"version":"build-2784847793"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82470125"],"award-info":[{"award-number":["82470125"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82470122 and 82200127"],"award-info":[{"award-number":["82470122 and 82200127"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CAMS Initiatives for Innovative Medicine","award":["2021-I2M-1-060"],"award-info":[{"award-number":["2021-I2M-1-060"]}]},{"name":"National Key Research and Development Program of China","award":["2023YFC3403802"],"award-info":[{"award-number":["2023YFC3403802"]}]},{"name":"Advanced Talents Training Program of Chengdu Medical College","award":["KYPY22-01"],"award-info":[{"award-number":["KYPY22-01"]}]},{"name":"CMC Excellent-talent program","award":["2024yxGzn03"],"award-info":[{"award-number":["2024yxGzn03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Hematol Oncol"],"DOI":"10.1186\/s40164-025-00742-4","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T07:33:10Z","timestamp":1768894390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ELK1 promotes the progress of myeloid leukemia by hindering the differentiation of neutrophils"],"prefix":"10.1186","volume":"15","author":[{"given":"Yuhan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongqun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sizhou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"issue":"5","key":"742_CR1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.6004\/jnccn.2023.0025","volume":"21","author":"DA Pollyea","year":"2023","unstructured":"Pollyea DA, et al. Acute myeloid Leukemia, version 3.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2023;21(5):503\u201313.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"742_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/jamaoncol.2021.5206","volume":"8","author":"MA Kutny","year":"2022","unstructured":"Kutny MA, et al. Assessment of arsenic trioxide and All-trans retinoic acid for the treatment of pediatric acute promyelocytic leukemia: A report from the children\u2019s oncology group AAML1331 trial. JAMA Oncol. 2022;8(1):79\u201387.","journal-title":"JAMA Oncol"},{"key":"742_CR3","doi-asserted-by":"crossref","unstructured":"Hanno, Hock et al. Intrinsic Requirement for Zinc Finger Transcription Factor Gfi-1 in Neutrophil Differentiation. immunity, 2003. 18: pp. 109\u2013120.","DOI":"10.1016\/S1074-7613(02)00501-0"},{"issue":"24","key":"742_CR4","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1182\/blood-2016-01-695759","volume":"127","author":"R Avellino","year":"2016","unstructured":"Avellino R, et al. An autonomous CEBPA enhancer specific for myeloid-lineage priming and neutrophilic differentiation. Blood. 2016;127(24):2991\u20133003.","journal-title":"Blood"},{"issue":"23","key":"742_CR5","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1182\/blood.2018886077","volume":"133","author":"Pavithra","year":"2019","unstructured":"Pavithra, Shyamsunder, et al. Identification of a novel enhancer of CEBPE essential for granulocytic differentiation. Blood. 2019;133(23):2507\u201317.","journal-title":"Blood"},{"issue":"9","key":"742_CR6","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1182\/blood-2014-09-600833","volume":"125","author":"A Y\u00e1\u00f1ez","year":"2015","unstructured":"Y\u00e1\u00f1ez A, et al. IRF8 acts in lineage-committed rather than oligopotent progenitors to control neutrophil vs monocyte production. Blood. 2015;125(9):1452\u20139.","journal-title":"Blood"},{"issue":"1","key":"742_CR7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12967-019-1944-x","volume":"17","author":"K Li","year":"2019","unstructured":"Li K, et al. CEBPE expression is an independent prognostic factor for acute myeloid leukemia. J Transl Med. 2019;17(1):188.","journal-title":"J Transl Med"},{"issue":"6","key":"742_CR8","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/leu.2016.11","volume":"30","author":"JM Hones","year":"2016","unstructured":"Hones JM, et al. GFI1 as a novel prognostic and therapeutic factor for AML\/MDS. Leukemia. 2016;30(6):1237\u201345.","journal-title":"Leukemia"},{"issue":"2","key":"742_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41375-024-02140-x","volume":"38","author":"J-A Georgi","year":"2024","unstructured":"Georgi J-A, et al. Prognostic impact of CEBPA mutational subgroups in adult AML. Leukemia. 2024;38(2):281\u201390.","journal-title":"Leukemia"},{"issue":"20","key":"742_CR10","doi-asserted-by":"publisher","first-page":"4116","DOI":"10.1038\/sj.emboj.7600419","volume":"23","author":"H Zeng","year":"2004","unstructured":"Zeng H, et al. Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells. EMBO J. 2004;23(20):4116\u201325.","journal-title":"EMBO J"},{"issue":"5","key":"742_CR11","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1182\/bloodadvances.2021005851","volume":"6","author":"R Avellino","year":"2022","unstructured":"Avellino R, et al. Induced cell-autonomous neutropenia systemically perturbs hematopoiesis in Cebpa enhancer-null mice. Blood Adv. 2022;6(5):1406\u201319.","journal-title":"Blood Adv"},{"key":"742_CR12","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3389\/fimmu.2018.00588","volume":"9","author":"NK Serwas","year":"2018","unstructured":"Serwas NK, et al. CEBPE-Mutant specific granule deficiency correlates with aberrant granule organization and substantial proteome alterations in neutrophils. Front Immunol. 2018;9:588.","journal-title":"Front Immunol"},{"issue":"3","key":"742_CR13","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1182\/blood-2013-12-541730","volume":"124","author":"L Xue","year":"2014","unstructured":"Xue L, et al. NrasG12D oncoprotein inhibits apoptosis of preleukemic cells expressing Cbf\u03b2-SMMHC via activation of MEK\/ERK axis. Blood. 2014;124(3):426\u201336.","journal-title":"Blood"},{"issue":"12","key":"742_CR14","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.1038\/s41375-021-01278-2","volume":"35","author":"SA Carratt","year":"2021","unstructured":"Carratt SA, et al. Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia. Leukemia. 2021;35(12):3594\u20139.","journal-title":"Leukemia"},{"key":"742_CR15","doi-asserted-by":"crossref","unstructured":"Jay F, Dorsey JMC, Shrikant M, Mane, Wu J. Regulation ofthe Erk2-Elk1 signaling pathway and megakaryocytic differentiation ofBcr-Abl K562 leukemic cells by Gab2. blood, 2002.","DOI":"10.1182\/blood.V99.4.1388"},{"key":"742_CR16","doi-asserted-by":"crossref","unstructured":"Gao Y et al. Mechanical strain promotes skin fibrosis through LRG-1 induction mediated by ELK1 and ERK signalling. Commun Biology, 2019. 2(1).","DOI":"10.1038\/s42003-019-0600-6"},{"issue":"22","key":"742_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI161308","volume":"132","author":"K Li","year":"2022","unstructured":"Li K, et al. BCL6 is regulated by the MAPK\/ELK1 axis and promotes KRAS-driven lung cancer. J Clin Invest. 2022;132(22):1\u201315.","journal-title":"J Clin Invest"},{"key":"742_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.canlet.2017.09.041","volume":"411","author":"J Ma","year":"2017","unstructured":"Ma J, et al. BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1\/ERK\/ELK1 signaling\u0431in\u0431hepatocellular carcinoma. Cancer Lett. 2017;411:117\u201329.","journal-title":"Cancer Lett"},{"issue":"9","key":"742_CR19","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1182\/blood-2004-05-2021","volume":"105","author":"WF Khalaf","year":"2005","unstructured":"Khalaf WF, et al. K-Ras is essential for normal fetal liver erythropoiesis. Blood. 2005;105(9):3538\u201341.","journal-title":"Blood"},{"key":"742_CR20","doi-asserted-by":"crossref","unstructured":"Zhang Y, et al. Small-molecule \u03b1-lipoic acid targets ELK1 to balance human neutrophil and erythrocyte differentiation. Volume 15. Stem Cell Research & Therapy; 2024. 1.","DOI":"10.1186\/s13287-024-03711-6"},{"issue":"29","key":"742_CR21","doi-asserted-by":"publisher","first-page":"26293","DOI":"10.1074\/jbc.M202301200","volume":"277","author":"G Behre","year":"2002","unstructured":"Behre G, et al. Ras signaling enhances the activity of C\/EBP\u03b1 to induce granulocytic differentiation by phosphorylation of Serine 248. J Biol Chem. 2002;277(29):26293\u20139.","journal-title":"J Biol Chem"},{"key":"742_CR22","doi-asserted-by":"publisher","first-page":"102392","DOI":"10.1016\/j.redox.2022.102392","volume":"54","author":"Y Dong","year":"2022","unstructured":"Dong Y, et al. Dissecting the process of human neutrophil lineage determination by using alpha-lipoic acid inducing neutrophil deficiency model. Redox Biol. 2022;54:102392.","journal-title":"Redox Biol"},{"key":"742_CR23","doi-asserted-by":"crossref","unstructured":"Anastasia Mylona F-XT, 2\u2020 C, Foster TM. Cheng,3 Francesc Miralles,1,4 Paul A. Bates,3 Philipp Selenko,2 Richard Treisman1\u2021, Opposing effects of Elk-1 multisite phosphorylation shape its response to ERK activation. Science, 2016. 354(6309): pp. 233\u2013237.","DOI":"10.1126\/science.aad1872"},{"issue":"20","key":"742_CR24","doi-asserted-by":"publisher","first-page":"5666","DOI":"10.1093\/emboj\/18.20.5666","volume":"18","author":"PS Shen-Hsi Yang","year":"1999","unstructured":"Shen-Hsi Yang PS, Willingham N, Jeremy H.Lakey and, Andrew D, Sharrocks. The mechanism of phosphorylation-inducible activation of the ETS-domain transcription factor Elk-1. EMBO J. 1999;18(20):5666\u201374.","journal-title":"EMBO J"},{"key":"742_CR25","doi-asserted-by":"crossref","unstructured":"Dong Y et al. Synergy of NUP98-HOXA10 fusion gene and NrasG12D mutation preserves the stemness of hematopoietic stem cells on culture condition. Cells, 2019. 8(9).","DOI":"10.3390\/cells8090951"},{"issue":"3","key":"742_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41590-018-0046-x","volume":"19","author":"M Zhang","year":"2018","unstructured":"Zhang M, et al. Transcription factor Hoxb5 reprograms B cells into functional T lymphocytes. Nat Immunol. 2018;19(3):279\u201390.","journal-title":"Nat Immunol"},{"issue":"3","key":"742_CR27","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nprot.2009.236","volume":"5","author":"F Tang","year":"2010","unstructured":"Tang F, et al. RNA-Seq analysis to capture the transcriptome landscape of a single cell. Nat Protoc. 2010;5(3):516\u201335.","journal-title":"Nat Protoc"},{"issue":"4","key":"742_CR28","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/JLB.1A1217-480R","volume":"104","author":"T Wang","year":"2018","unstructured":"Wang T, et al. Trim27 confers myeloid hematopoiesis competitiveness by up-regulating myeloid master genes. J Leukoc Biol. 2018;104(4):799\u2013809.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"742_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/MOH.0000000000000567","volume":"27","author":"A Kishtagari","year":"2020","unstructured":"Kishtagari A, Levine RL, Viny AD. Driver mutations in acute myeloid leukemia. Curr Opin Hematol. 2020;27(2):49\u201357.","journal-title":"Curr Opin Hematol"},{"issue":"5","key":"742_CR30","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1182\/blood-2016-01-693879","volume":"128","author":"KH Metzeler","year":"2016","unstructured":"Metzeler KH, et al. Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia. Blood. 2016;128(5):686\u201398.","journal-title":"Blood"},{"key":"742_CR31","unstructured":"Kwok I et al. Combinatorial Single-Cell Analyses of Granulocyte-Monocyte Progenitor Heterogeneity Reveals an Early Uni-potent Neutrophil Progenitor. Immunity, 2020."},{"issue":"1","key":"742_CR32","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1128\/MCB.24.1.294-305.2004","volume":"24","author":"F Cesari","year":"2004","unstructured":"Cesari F, et al. Mice deficient for the Ets transcription factor Elk-1 show normal immune responses and mildly impaired neuronal gene activation. Mol Cell Biol. 2004;24(1):294\u2013305.","journal-title":"Mol Cell Biol"},{"issue":"25","key":"742_CR33","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1182\/blood.2021010745","volume":"138","author":"JC Bernhard Lehnertz","year":"2021","unstructured":"Bernhard Lehnertz JC, MacRae T, Tomellini E, Corneau S, Mayotte N, Boivin I. Aur\u00e9lie Durand, Deanne Gracias, guy Sauvageau, HLF expression defines the human hematopoietic stem cell state. Blood. 2021;138(25):2642\u201354.","journal-title":"Blood"},{"issue":"20","key":"742_CR34","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1182\/blood-2014-03-558825","volume":"124","author":"V Ramos-Mejia","year":"2014","unstructured":"Ramos-Mejia V, et al. HOXA9 promotes hematopoietic commitment of human embryonic stem cells. Blood. 2014;124(20):3065\u201375.","journal-title":"Blood"},{"issue":"6","key":"742_CR35","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.stem.2007.10.020","volume":"1","author":"H Yoshihara","year":"2007","unstructured":"Yoshihara H, et al. Thrombopoietin\/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell. 2007;1(6):685\u201397.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"742_CR36","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.stem.2008.01.015","volume":"2","author":"IM Min","year":"2008","unstructured":"Min IM, et al. The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells. Cell Stem Cell. 2008;2(4):380\u201391.","journal-title":"Cell Stem Cell"},{"key":"742_CR37","doi-asserted-by":"publisher","first-page":"854973","DOI":"10.3389\/fonc.2022.854973","volume":"12","author":"KJ Kurtz","year":"2022","unstructured":"Kurtz KJ, et al. Murine models of acute myeloid leukemia. Front Oncol. 2022;12:854973.","journal-title":"Front Oncol"},{"issue":"2","key":"742_CR38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/gene.20003","volume":"38","author":"F Cesari","year":"2004","unstructured":"Cesari F, et al. Elk-1 knock-out mice engineered by Flp recombinase-mediated cassette exchange. Genesis. 2004;38(2):87\u201392.","journal-title":"Genesis"},{"key":"742_CR39","doi-asserted-by":"crossref","unstructured":"Li T et al. LSP1 promotes the progression of acute myelogenous leukemia by regulating KSR\/ERK signaling pathway and cell migration. Hematology, 2024. 29(1).","DOI":"10.1080\/16078454.2024.2330285"},{"key":"742_CR40","doi-asserted-by":"crossref","unstructured":"Zhu L et al. THBS1 is a novel serum prognostic factors of acute myeloid leukemia. Front Oncol, 2020. 9.","DOI":"10.3389\/fonc.2019.01567"},{"issue":"1\u20132","key":"742_CR41","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41417-019-0093-y","volume":"27","author":"Y Liu","year":"2020","unstructured":"Liu Y, et al. High IFITM3 expression predicts adverse prognosis in acute myeloid leukemia. Cancer Gene Ther. 2020;27(1\u20132):38\u201344.","journal-title":"Cancer Gene Ther"},{"issue":"26","key":"742_CR42","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1182\/blood-2014-05-574582","volume":"124","author":"MR Burgess","year":"2014","unstructured":"Burgess MR, et al. Preclinical efficacy of MEK Inhibition in Nras-mutant AML. Blood. 2014;124(26):3947\u201355.","journal-title":"Blood"},{"issue":"5","key":"742_CR43","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41591-018-0011-0","volume":"24","author":"K Apazoglou","year":"2018","unstructured":"Apazoglou K, et al. Antidepressive effects of targeting ELK-1 signal transduction. Nat Med. 2018;24(5):591\u20137.","journal-title":"Nat Med"},{"issue":"52","key":"742_CR44","doi-asserted-by":"publisher","first-page":"14448","DOI":"10.1523\/JNEUROSCI.2279-07.2007","volume":"27","author":"J Lavaur","year":"2007","unstructured":"Lavaur J, et al. A TAT\u2013DEF\u2013Elk-1 peptide regulates the cytonuclear trafficking of Elk-1 and controls cytoskeleton dynamics. J Neurosci. 2007;27(52):14448\u201358.","journal-title":"J Neurosci"},{"issue":"9","key":"742_CR45","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1073\/pnas.0813280106","volume":"106","author":"J Hu","year":"2009","unstructured":"Hu J, et al. Long-term efficacy and safety of all-trans retinoic acid\/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci U S A. 2009;106(9):3342\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"742_CR46","doi-asserted-by":"crossref","unstructured":"Lyubynska N et al. A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice. Sci Transl Med, 2011. 3(76).","DOI":"10.1126\/scitranslmed.3001069"},{"issue":"23","key":"742_CR47","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374(23):2209\u201321.","journal-title":"N Engl J Med"},{"issue":"9","key":"742_CR48","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1128\/MCB.06751-11","volume":"32","author":"G Rahim","year":"2023","unstructured":"Rahim G, et al. Alternative splicing within the elk-1 5\u2032 untranslated region serves to modulate initiation events downstream of the highly conserved upstream open reading frame 2. Mol Cell Biol. 2023;32(9):1745\u201356.","journal-title":"Mol Cell Biol"},{"issue":"7","key":"742_CR49","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1074\/jbc.M006678200","volume":"276","author":"P Vanhoutte","year":"2001","unstructured":"Vanhoutte P, et al. Opposing roles of Elk-1 and its brain-specific isoform, short Elk-1, in nerve growth factor-induced PC12 differentiation. J Biol Chem. 2001;276(7):5189\u201396.","journal-title":"J Biol Chem"}],"container-title":["Experimental Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40164-025-00742-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-025-00742-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-025-00742-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T16:18:13Z","timestamp":1769098693000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40164-025-00742-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["742"],"URL":"https:\/\/doi.org\/10.1186\/s40164-025-00742-4","relation":{},"ISSN":["2162-3619"],"issn-type":[{"value":"2162-3619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval and consent to participate. This research does not contain clinical experiments. All the animal experiments are performed at Chengdu Medical College. All animal experiments were approved by the Institutional Animal Care and Use Committee of Chengdu Medical College. The Approval Number is 2024-043.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors agree to publish the results of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}